IP Verse

Teva Pharmaceuticals International Gmbh opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Oct 6, 2021

Title:

Solid State Forms Of Lumateperone Ditosylate Salt

Oppositions:

Patent:

Grant Date:

Nov 6, 2019

Title:

Solid State Forms Of Selexipag

Oppositions:

Patent:

Grant Date:

Mar 7, 2018

Title:

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same

Oppositions:

Patent:

Grant Date:

Mar 8, 2017

Title:

Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3497104	Oct 6, 2021	Solid State Forms Of Lumateperone Ditosylate Salt	1
EP3344607	Nov 6, 2019	Solid State Forms Of Selexipag	2
EP3045182	Mar 7, 2018	Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same	2
EP2688877	Mar 8, 2017	Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof	1

BREUER, MARKUS

CHIESI FARMACEUTICI S.P.A.

ELI LILLY AND COMPANY

Feel free to send us a message here and we will get back to you